Attached files
Exhibit 3.2
CERTIFICATE OF DESIGNATION OF PREFERENCES,
RIGHTS AND LIMITATIONS
OF
SERIES K CONVERTIBLE PREFERRED STOCK
The
undersigned, Chief Executive Officer of MABVAX THERAPEUTICS
HOLDINGS, INC., a Delaware corporation (the
“Corporation”), DOES HEREBY CERTIFY that the following
resolutions were duly adopted by the Board of Directors of the
Corporation on August 11, 2017;
WHEREAS, the Board of Directors is
authorized within the limitations and
restrictions stated in the Certificate of Incorporation of the
Corporation, as amended, to provide by resolution or resolutions
for the issuance of Sixty-five
Thousand (65,000) shares of Preferred Stock, par value $0.01 per share, of the Corporation, in
such series and with such designations, preferences and relative,
participating, optional or other special rights and qualifications,
limitations or restrictions as the Corporation’s Board of
Directors shall fix by resolution or resolutions providing for the
issuance thereof duly adopted by the Board of Directors;
and
WHEREAS, it is the desire of the Board of
Directors, pursuant to its authority as aforesaid, to authorize and
fix the terms of a series of Preferred Stock and the number of
shares constituting such series;
NOW,
THEREFORE, BE IT RESOLVED:
Section
1. Designation and
Authorized Shares. The
Corporation shall be authorized to issue Sixty-Five Thousand (65,000) shares of Series K
Preferred Stock, par value
$0.01 per share (the “Series K Preferred
Stock”).
Section
2. Stated
Value. Each share of Series K
Preferred Stock shall have a stated value of $0.01 per share
(as subject to adjustment in the case of any stock splits, stock
combination or similar recapitalization affecting the Series K
Preferred Stock as set forth herein) (the “Stated Value”).
Section
3. Liquidation.
(a) Upon
the liquidation, dissolution or winding up of the business of the
Corporation, whether voluntary or involuntary, each holder of
Series K Preferred Stock shall be entitled to receive, for each
share thereof, out of assets of the Corporation legally available
therefor, a preferential amount in cash equal to (and not more
than) the Stated Value. All preferential amounts to be paid to the
holders of Series K Preferred Stock in connection with such
liquidation, dissolution or winding up shall be paid before the
payment or setting apart for payment of any amount for, or the
distribution of any assets of the Corporation to the holders of (i)
any other class or series of capital stock whose terms expressly
provide that the holders of Series K Preferred Stock should receive
preferential payment with respect to such distribution (to the
extent of such preference) and (ii) the Corporation's Common
Stock. If upon any such
distribution the assets of the Corporation shall be insufficient to
pay the holders of the outstanding shares of Series K Preferred
Stock (or the holders of any class or series of capital stock
ranking on a parity with the Series K Preferred Stock as to
distributions in the event of a liquidation, dissolution or winding
up of the Corporation) the full amounts to which they shall be
entitled, such holders shall share ratably in any distribution of
assets in accordance with the sums which would be payable on such
distribution if all sums payable thereon were paid in
full.
(b) Any
distribution in connection with the liquidation, dissolution or
winding up of the Corporation, or any bankruptcy or insolvency
proceeding, shall be made in cash to the extent possible. Whenever
any such distribution shall be paid in property other than cash,
the value of such distribution shall be the fair market value of
such property as determined in good faith by the Board of Directors
of the Corporation.
-1-
Section
4. Conversion.
(a) Conversion Right. Each holder of Series K Preferred
Stock may, from time to time, convert any or all of such
holder’s shares of Series K Preferred Stock into fully paid
and non-assessable shares of Common Stock according to the
following formula:
Stated Value
Conversion
Price
“Conversion
Price” shall equal $0.0001.
Notwithstanding
anything herein to the contrary, if the Corporation has not
obtained the approval of its shareholders in accordance with the
rules of the Nasdaq Stock Market LLC for the conversion of Series J
Preferred Stock authorized on August 11, 2017 or the conversion of
Series K Preferred Stock (“Shareholder Approval”), then
the Corporation may not issue upon conversion of Series K Preferred
Stock any shares of Common Stock.
(b) Conversion Procedure.
In order to exercise the conversion privilege under this Section 4,
the holder of any shares of Series K Preferred Stock to be
converted shall give written notice to the Corporation at its
principal office that such holder elects to convert such shares of
Series K Preferred Stock or a specified portion thereof into shares
of Common Stock as set forth in such notice (the “Conversion
Notice”, and such date of delivery of the Conversion Notice
to the Corporation, the “Conversion Notice Delivery
Date”). Within three (3) business days following the
Conversion Notice Delivery Date, the Corporation shall issue and
deliver a certificate or certificates representing the number of
shares of Common Stock determined pursuant to this Section 4 (the
“Share Delivery Date”). In case of conversion under
this Section 4 of only a part of the shares of Series K Preferred
Stock represented by a certificate surrendered to the Corporation,
the Corporation shall issue and deliver a new certificate for the
number of shares of Series K Preferred Stock which have not been
converted, upon receipt of the original certificate or certificates
representing shares of Series K Preferred Stock so converted. Until
such time as the certificate or certificates representing shares of
Series K Preferred Stock which have been converted are surrendered
to the Corporation and a certificate or certificates representing
the Common Stock into which such shares of Series K Preferred Stock
have been converted have been issued and delivered, the certificate
or certificates representing the shares of Series K Preferred Stock
which have been converted shall represent the shares of Common
Stock into which such shares of Series K Preferred Stock have been
converted. The Corporation shall pay all documentary, stamp or
similar issue or transfer tax due on the issue of shares of Common
Stock issuable upon conversion of the Series K Preferred
Stock.
(c) Maximum
Conversion.
(i)
Notwithstanding
anything to the contrary set forth in this Certificate of
Designation, at no time may all or a portion of shares of Series K
Preferred Stock be converted if the number of shares of Common
Stock to be issued pursuant to such conversion would exceed,
when aggregated with all other shares of Common Stock owned by such
holder at such time, the number of shares of Common Stock which
would result in such holder beneficially owning (as determined in
accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”) and the rules
thereunder) more than 4.99% of all of the Common Stock outstanding
at such time (the “4.99% Beneficial Ownership
Limitation”).
(ii)
By written notice
to the Corporation, any holder of Series K Preferred Stock may
increase or decrease the 4.99% Beneficial Ownership Limitation to
any other percentage not in excess of 9.99% specified in such
notice; provided that (i) any such increase will not be effective
until the 61st day after such notice is delivered to the
Corporation, and (ii) any such increase or decrease will apply only
to such holder of Series K Preferred Stock sending such notice and
not to any other holder of Series K Preferred Stock.
-2-
(iii)
For purposes of
this Section 4, in determining the number of outstanding shares of
Common Stock, a holder of Series K Preferred Stock may rely on the
number of outstanding shares of Common Stock as reflected in (1)
the Corporation’s most recent Form 10-K, Form 10-Q, Current
Report on Form 8-K or other public filing with the Securities and
Exchange Commission, as the case may be, (2) a more recent public
announcement by the Corporation or (3) any other notice by the
Corporation setting forth the number of shares of Common Stock
outstanding. For any reason at any time, upon the written or oral
request of a holder of Series K Preferred Stock, the Corporation
shall within one (1) business day confirm orally and in writing to
such holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of
securities of the Corporation, including shares of Series K
Preferred Stock, held by such holder and its affiliates since the
date as of which such number of outstanding shares of Common Stock
was reported, which in any event are convertible or exercisable, as
the case may be, into shares of the Corporation’s Common
Stock within sixty (60) days’ of such calculation and which
are not subject to a limitation on conversion or exercise analogous
to the limitation contained herein. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section 4 to correct this
paragraph (or any portion hereof) which may be defective or
inconsistent with the intended beneficial ownership limitation
herein contained or to make changes or supplements necessary or
desirable to properly give effect to such
limitation.
(d)
Buy-In. If, by the Share
Delivery Date, and provided the Corporation has obtained
Shareholder Approval, the Corporation fails for any reason to
deliver the shares of Common Stock issuable upon conversion of the
Series K Preferred Stock, as set forth in the Conversion Notice,
and after such Share Delivery Date, the converting holder
purchases, in an arm’s length open market transaction or
otherwise, shares of Common Stock (the “Covering
Shares”) in order to make delivery in satisfaction of a sale
of Common Stock by the converting holder (the “Sold
Shares”), which delivery such converting holder anticipated
to make using the shares to be issued upon such conversion (a
“Buy-In”), the converting holder shall have the right
to require the Corporation to pay to the converting holder the
Buy-In Adjustment Amount. The Corporation shall pay the
Buy-In Adjustment Amount to the converting holder in immediately
available funds immediately upon demand by the converting holder.
For purposes of this Certificate of Designation, the term
“Buy-In Adjustment Amount” means the amount equal to
the excess, if any, of (i) the converting holder’s total
purchase price (including brokerage commissions, if any) for the
Covering Shares associated with a Buy-In, over (ii) the net
proceeds (after brokerage commissions, if any) received by the
converting holder from the sale of the Sold Shares. By
way of illustration and not in limitation of the foregoing, if the
converting holder purchases shares of Common Stock having a total
purchase price (including brokerage commissions) of $11,000 to
cover a Buy-In, with respect to shares of Common Stock it sold for
net proceeds of $10,000, the Buy-In Adjustment Amount which the
Corporation will be required to pay to the converting holder will
be $1,000.
Section
5. Voting.
Except as otherwise expressly required by law, each holder of
Series K Preferred Stock shall be entitled to vote on all matters
submitted to shareholders of the Corporation and shall be entitled
to the number of votes for each share of Series K Preferred Stock
owned at the record date for the determination of shareholders
entitled to vote on such matter or, if no such record date is
established, at the date such vote is taken or any written consent
of shareholders is solicited, equal to the number of shares of
Common Stock such shares of Series K Preferred Stock are
convertible into at such time, substituting the consolidated
Closing Bid Price on August 10, 2017 for the Conversion Price in
Section 4(a) hereof but not in excess
of the conversion limitations set forth in Section 4
herein.
“Closing Bid
Price” means, for any security as of any date, the last
closing bid price and last closing trade price, respectively, for
such security on the Nasdaq Stock Market LLC (the “Principal
Market”), as reported by Bloomberg, or, if the Principal
Market begins to operate on an extended hours basis and does not
designate the closing bid price or the closing trade price (as the
case may be) then the last bid price or last trade price,
respectively, of such security prior to 4:00:00 p.m., New York
time, as reported by Bloomberg, or, if the Principal Market is not
the principal securities exchange or trading market for such
security, the last closing bid price or last trade price,
respectively, of such security on the principal securities exchange
or trading market where such security is listed or traded as
reported by Bloomberg, or if the foregoing do not apply, the last
closing bid price or last trade price, respectively, of such
security in the over-the-counter market on the electronic bulletin
board for such security as reported by Bloomberg, or, if no closing
bid price or last trade price, respectively, is reported for such
security by Bloomberg, the average of the bid prices, or the ask
prices, respectively, of any market makers for such security as
reported in the “pink sheets” by OTC Markets Group Inc.
(formerly Pink Sheets LLC). If the Closing Bid Price cannot be
calculated for a security on a particular date on any of the
foregoing bases, the Closing Bid Price of such security on such
date shall be the fair market value as mutually determined by the
Company and the applicable Holder. All such determinations shall be
appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such
period.
-3-
Section
6. Other
Provisions.
(a) Reservation
of Common Stock. The
Corporation shall at all times reserve
from its authorized Common Stock a sufficient number of shares to
provide for conversion of all Series K Preferred Stock from time to
time outstanding.
(b) Record
Holders. The Corporation and
its transfer agent, if any, for the Series K Preferred Stock may
deem and treat the record holder of any shares of Series K
Preferred Stock as reflected on the books and records of the
Corporation as the sole true and lawful owner thereof for all
purposes, and neither the Corporation nor any such transfer agent
shall be affected by any notice to the
contrary.
Section
7. Restriction and Limitations.
Except as expressly provided herein or as required by law so long
as any shares of Series K Preferred Stock remain outstanding, the
Corporation shall not, without the vote or written consent of the
holders of at least a majority of the then outstanding shares of
the Series K Preferred Stock, take any action which would adversely
and materially affect any of the preferences, limitations or
relative rights of the Series K Preferred Stock.
Section
8. Certain
Adjustments.
(a) Stock Dividends and Stock
Splits. If the Corporation, at any time while the Series K
Preferred Stock is outstanding: (A) shall pay a stock dividend or
otherwise make a distribution or distributions on shares of its
Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt,
shall not include any shares of Common Stock issued by the
Corporation pursuant to the conversion of the Series K Preferred
Stock), (B) subdivide outstanding shares of Common Stock into a
larger number of shares, (C) combine (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller
number of shares, or (D) issue by reclassification of shares of the
Common Stock any shares of capital stock of the Corporation, each
share of Series K Preferred Stock shall receive such consideration
as if such number of shares of Series K Preferred had been,
immediately prior to such foregoing dividend, distribution,
subdivision, combination or reclassification, the holder of the
number of shares of Common Stock into which it could convert at
such time. Any adjustment made pursuant to this Section shall
become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or
re-classification.
Section
9. Equal Treatment of Holders. No
consideration (including any modification of this Certificate of
Designation or related transaction document) shall be offered or
paid to any person or entity to amend or consent to a waiver or
modification of any provision of this Certificate of Designation or
related transaction document unless the same consideration is also
offered to all of holders of the outstanding shares of Series K
Preferred Stock. For clarification purposes, this provision
constitutes a separate right granted to each holder by the
Corporation and negotiated separately by each holder, and is
intended for the Corporation to treat all holders of the Series K
Preferred Stock as a class and shall not in any way be construed as
such holders acting in concert or as a group with respect to the
purchase, disposition or voting of the Series K Preferred Stock or
otherwise.
[signature page follows]
-4-
IN
WITNESS WHEREOF, the undersigned has executed this Certificate this
[___] day of August, 2017.
By:________________________
Name:
Title:
-5-